Correlation Between PDS Biotechnology and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Aytu BioScience, you can compare the effects of market volatilities on PDS Biotechnology and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Aytu BioScience.
Diversification Opportunities for PDS Biotechnology and Aytu BioScience
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between PDS and Aytu is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Aytu BioScience go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Aytu BioScience
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Aytu BioScience. In addition to that, PDS Biotechnology is 1.26 times more volatile than Aytu BioScience. It trades about -0.27 of its total potential returns per unit of risk. Aytu BioScience is currently generating about -0.16 per unit of volatility. If you would invest 192.00 in Aytu BioScience on September 1, 2024 and sell it today you would lose (31.00) from holding Aytu BioScience or give up 16.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
PDS Biotechnology Corp vs. Aytu BioScience
Performance |
Timeline |
PDS Biotechnology Corp |
Aytu BioScience |
PDS Biotechnology and Aytu BioScience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PDS Biotechnology and Aytu BioScience
The main advantage of trading using opposite PDS Biotechnology and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |